Povi-One, 10% recall — Elevate Oral Care (Class II)

Elevate Oral Care is recorded by the U.S. Food and Drug Administration (FDA) as recalling Povi-One, 10% — a Class II recall, initiated 2026-06-04 and posted to the FDA enforcement report on 2026-07-01, under recall number D-0627-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “sub potency”. From the product description, the strength given is 10%. 1 National Drug Code number is printed in the record: 57511-0611-1. Distribution is recorded as “Nationwide” — Nationwide (US), with the recalling firm on record in FL, United States. It is the only recall number the FDA has filed under event ID 99191. 27 days separate the firm's initiation date from the FDA's report date on this record. 213 of the indexed records carry the same Class II tier. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0627-2026
FDA event ID 99191
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Elevate Oral Care
Recall initiated 2026-06-04
Reported by FDA 2026-07-01
Report lag 27 days from initiation to report
Distribution Nationwide — Nationwide (US)
Firm location on record FL, United States
Product description (source) Povi-One, 10% Povidone-Iodine Oral Antiseptic, Packaged by Elevate Oral Care, LLC, 346 Pike Road, Suite 6, West Palm Beach, FL 33411, NDC 57511-0611-1.

Reason reported by FDA

sub potency

2 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

2 identifying values matched by exact pattern in the 23-word product description above; each is a literal substring of it.

Product named Povi-One
Strength 10%
NDC 57511-0611-1

Reported in the same month (2026-07)

111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
MAJOR, 0.2 mgD-0609-2026The Harvard Drug Group LLCClass II2026-07-01
Fenofibrate Capsules, 200 mgD-0611-2026Ajanta Pharma Usa IncClass II2026-07-01
Corlanor (ivabradine) tablets, 5 mgD-0612-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 30mgD-0613-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 60mgD-0614-2026Amgen, Inc.Class II2026-07-01
Corlanor (ivabradine) tablets, 7.5mgD-0615-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 90mgD-0616-2026Amgen, Inc.Class II2026-07-01
DULOXETINE D/R, 30 mgD-0617-2026Direct RXClass II2026-07-01

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 8 nearest to 2026-07-01 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, 1295 mLD-0618-2026Central Admixture Pharmacy Services, Inc.1295 mL · Injection2026-07-01
PReye Vitamin See Antioxidant Preservative Free Eye DropsD-0621-2026Preye LLCEye Drops2026-07-01
BD ChloraPrep Clear, 2%D-0622-2026Carefusion 213, LLC2% · Solution2026-07-01
BD ChloraPrep FREPP Clear, 2%D-0623-2026Carefusion 213, LLC2% · Solution2026-07-01
Lacosamide Tablets, 100mgD-0626-2026Annora Pharma Private Ltd100mg · Tablets2026-07-01
Perampanel CIII Tablets, 6mgD-0628-2026Sun Pharmaceutical Industries Inc6mg · Tablets2026-07-01
Alyacen 7/7/7, 0.5mg/0.035mgD-0588-2026Glenmark Pharmaceuticals Inc., Usa0.5mg/0.035mg · Tablets2026-06-24
VistaPharm, 25 GramsD-0589-2026Pai Holdings LLC25 Grams2026-06-24

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 57511-0611-1 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Elevate Oral Care (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0627-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0627-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-07-01
Ingested
2026-08-22
Record hash
2785c14de20f1945

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.